nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—prostate cancer—testicular cancer	0.645	1	CtDrD
Abiraterone—ABCC1—Dactinomycin—testicular cancer	0.0524	0.196	CbGbCtD
Abiraterone—ABCC1—Epirubicin—testicular cancer	0.038	0.142	CbGbCtD
Abiraterone—ABCC1—Vinblastine—testicular cancer	0.0328	0.123	CbGbCtD
Abiraterone—ABCC1—Etoposide—testicular cancer	0.0296	0.111	CbGbCtD
Abiraterone—CYP2C8—Ifosfamide—testicular cancer	0.0221	0.0826	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—testicular cancer	0.0202	0.0755	CbGbCtD
Abiraterone—ABCC1—Methotrexate—testicular cancer	0.0195	0.0732	CbGbCtD
Abiraterone—CYP17A1—seminiferous tubule of testis—testicular cancer	0.0129	0.463	CbGeAlD
Abiraterone—CYP2C8—Etoposide—testicular cancer	0.0105	0.0395	CbGbCtD
Abiraterone—ALB—Methotrexate—testicular cancer	0.00901	0.0338	CbGbCtD
Abiraterone—CYP3A4—Ifosfamide—testicular cancer	0.00895	0.0335	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—testicular cancer	0.00746	0.0279	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—testicular cancer	0.00475	0.0178	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—testicular cancer	0.00459	0.0172	CbGbCtD
Abiraterone—CYP3A4—Etoposide—testicular cancer	0.00428	0.016	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—testicular cancer	0.00292	0.0109	CbGbCtD
Abiraterone—SULT2A1—gonad—testicular cancer	0.00252	0.09	CbGeAlD
Abiraterone—SULT2A1—female gonad—testicular cancer	0.00204	0.0732	CbGeAlD
Abiraterone—SULT2A1—testis—testicular cancer	0.00181	0.0649	CbGeAlD
Abiraterone—SULT2A1—lymph node—testicular cancer	0.00131	0.047	CbGeAlD
Abiraterone—CYP17A1—gonad—testicular cancer	0.00109	0.0392	CbGeAlD
Abiraterone—CYP17A1—female gonad—testicular cancer	0.00089	0.0318	CbGeAlD
Abiraterone—CYP17A1—testis—testicular cancer	0.000789	0.0282	CbGeAlD
Abiraterone—ABCC1—seminal vesicle—testicular cancer	0.00077	0.0276	CbGeAlD
Abiraterone—CYP17A1—lymph node—testicular cancer	0.000572	0.0205	CbGeAlD
Abiraterone—ALB—testis—testicular cancer	0.000486	0.0174	CbGeAlD
Abiraterone—ABCC1—female gonad—testicular cancer	0.000452	0.0162	CbGeAlD
Abiraterone—ORM1—lymph node—testicular cancer	0.000402	0.0144	CbGeAlD
Abiraterone—ABCC1—testis—testicular cancer	0.000401	0.0144	CbGeAlD
Abiraterone—ALB—lymph node—testicular cancer	0.000352	0.0126	CbGeAlD
Abiraterone—CYP2C8—testis—testicular cancer	0.000341	0.0122	CbGeAlD
Abiraterone—ABCC1—lymph node—testicular cancer	0.000291	0.0104	CbGeAlD
Abiraterone—CYP2D6—female gonad—testicular cancer	0.000257	0.00919	CbGeAlD
Abiraterone—CYP2D6—testis—testicular cancer	0.000228	0.00815	CbGeAlD
Abiraterone—Alanine aminotransferase increased—Etoposide—testicular cancer	0.000224	0.00375	CcSEcCtD
Abiraterone—Urinary tract disorder—Ifosfamide—testicular cancer	0.000219	0.00368	CcSEcCtD
Abiraterone—Connective tissue disorder—Ifosfamide—testicular cancer	0.000218	0.00366	CcSEcCtD
Abiraterone—Urethral disorder—Ifosfamide—testicular cancer	0.000218	0.00365	CcSEcCtD
Abiraterone—Nocturia—Epirubicin—testicular cancer	0.000211	0.00354	CcSEcCtD
Abiraterone—Acute coronary syndrome—Cisplatin—testicular cancer	0.00021	0.00353	CcSEcCtD
Abiraterone—Dyspepsia—Chlorambucil—testicular cancer	0.00021	0.00352	CcSEcCtD
Abiraterone—Anaemia—Bleomycin—testicular cancer	0.000209	0.00351	CcSEcCtD
Abiraterone—Myocardial infarction—Cisplatin—testicular cancer	0.000209	0.00351	CcSEcCtD
Abiraterone—Cardiac disorder—Ifosfamide—testicular cancer	0.000206	0.00346	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000206	0.00346	CcSEcCtD
Abiraterone—Fatigue—Chlorambucil—testicular cancer	0.000206	0.00345	CcSEcCtD
Abiraterone—Angiopathy—Ifosfamide—testicular cancer	0.000202	0.00338	CcSEcCtD
Abiraterone—Mediastinal disorder—Ifosfamide—testicular cancer	0.0002	0.00336	CcSEcCtD
Abiraterone—Arrhythmia—Ifosfamide—testicular cancer	0.000199	0.00333	CcSEcCtD
Abiraterone—Cough—Bleomycin—testicular cancer	0.000198	0.00331	CcSEcCtD
Abiraterone—Pneumonia—Etoposide—testicular cancer	0.000197	0.0033	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—testicular cancer	0.000196	0.00329	CcSEcCtD
Abiraterone—Infestation—Etoposide—testicular cancer	0.000196	0.00328	CcSEcCtD
Abiraterone—Infestation NOS—Etoposide—testicular cancer	0.000196	0.00328	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—testicular cancer	0.000195	0.00328	CcSEcCtD
Abiraterone—Anaemia—Dactinomycin—testicular cancer	0.000195	0.00327	CcSEcCtD
Abiraterone—Mental disorder—Ifosfamide—testicular cancer	0.000195	0.00327	CcSEcCtD
Abiraterone—Acute coronary syndrome—Etoposide—testicular cancer	0.000193	0.00323	CcSEcCtD
Abiraterone—Chest pain—Bleomycin—testicular cancer	0.000193	0.00323	CcSEcCtD
Abiraterone—Myalgia—Bleomycin—testicular cancer	0.000193	0.00323	CcSEcCtD
Abiraterone—Myocardial infarction—Etoposide—testicular cancer	0.000192	0.00321	CcSEcCtD
Abiraterone—Discomfort—Bleomycin—testicular cancer	0.00019	0.00319	CcSEcCtD
Abiraterone—Urinary tract disorder—Cisplatin—testicular cancer	0.000189	0.00317	CcSEcCtD
Abiraterone—Body temperature increased—Chlorambucil—testicular cancer	0.000189	0.00316	CcSEcCtD
Abiraterone—Connective tissue disorder—Cisplatin—testicular cancer	0.000188	0.00316	CcSEcCtD
Abiraterone—Urethral disorder—Cisplatin—testicular cancer	0.000188	0.00315	CcSEcCtD
Abiraterone—Constipation—Vinblastine—testicular cancer	0.000187	0.00314	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—testicular cancer	0.000186	0.00312	CcSEcCtD
Abiraterone—Oedema—Bleomycin—testicular cancer	0.000185	0.0031	CcSEcCtD
Abiraterone—Infection—Bleomycin—testicular cancer	0.000184	0.00308	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—testicular cancer	0.000181	0.00304	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—testicular cancer	0.00018	0.00301	CcSEcCtD
Abiraterone—Anaemia—Ifosfamide—testicular cancer	0.000179	0.003	CcSEcCtD
Abiraterone—Cardiac disorder—Cisplatin—testicular cancer	0.000178	0.00298	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—testicular cancer	0.000178	0.00298	CcSEcCtD
Abiraterone—Urinary tract disorder—Etoposide—testicular cancer	0.000173	0.00291	CcSEcCtD
Abiraterone—Mediastinal disorder—Cisplatin—testicular cancer	0.000173	0.0029	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—testicular cancer	0.000172	0.00289	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—testicular cancer	0.000172	0.00289	CcSEcCtD
Abiraterone—Urethral disorder—Etoposide—testicular cancer	0.000172	0.00289	CcSEcCtD
Abiraterone—Asthenia—Chlorambucil—testicular cancer	0.000171	0.00287	CcSEcCtD
Abiraterone—Infection—Dactinomycin—testicular cancer	0.000171	0.00287	CcSEcCtD
Abiraterone—Arrhythmia—Cisplatin—testicular cancer	0.000171	0.00287	CcSEcCtD
Abiraterone—Cough—Ifosfamide—testicular cancer	0.000169	0.00283	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000168	0.00282	CcSEcCtD
Abiraterone—Hypertension—Ifosfamide—testicular cancer	0.000167	0.0028	CcSEcCtD
Abiraterone—Dyspnoea—Bleomycin—testicular cancer	0.000165	0.00276	CcSEcCtD
Abiraterone—Chest pain—Ifosfamide—testicular cancer	0.000165	0.00276	CcSEcCtD
Abiraterone—Myalgia—Ifosfamide—testicular cancer	0.000165	0.00276	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000164	0.00274	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.000163	0.00274	CcSEcCtD
Abiraterone—Diarrhoea—Chlorambucil—testicular cancer	0.000163	0.00274	CcSEcCtD
Abiraterone—Cardiac disorder—Etoposide—testicular cancer	0.000163	0.00273	CcSEcCtD
Abiraterone—Discomfort—Ifosfamide—testicular cancer	0.000163	0.00273	CcSEcCtD
Abiraterone—Angiopathy—Etoposide—testicular cancer	0.000159	0.00267	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—testicular cancer	0.000158	0.00265	CcSEcCtD
Abiraterone—Oedema—Ifosfamide—testicular cancer	0.000158	0.00265	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000157	0.00263	CcSEcCtD
Abiraterone—Asthenia—Vinblastine—testicular cancer	0.000157	0.00263	CcSEcCtD
Abiraterone—Infection—Ifosfamide—testicular cancer	0.000157	0.00263	CcSEcCtD
Abiraterone—Anaemia—Cisplatin—testicular cancer	0.000154	0.00259	CcSEcCtD
Abiraterone—Skin disorder—Ifosfamide—testicular cancer	0.000153	0.00257	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—testicular cancer	0.000152	0.00255	CcSEcCtD
Abiraterone—Vomiting—Chlorambucil—testicular cancer	0.000152	0.00255	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.000151	0.00254	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—testicular cancer	0.000151	0.00253	CcSEcCtD
Abiraterone—Diarrhoea—Vinblastine—testicular cancer	0.00015	0.00251	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—testicular cancer	0.000149	0.00249	CcSEcCtD
Abiraterone—Body temperature increased—Bleomycin—testicular cancer	0.000146	0.00245	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—testicular cancer	0.000146	0.00244	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000144	0.00241	CcSEcCtD
Abiraterone—Myalgia—Cisplatin—testicular cancer	0.000142	0.00238	CcSEcCtD
Abiraterone—Anaemia—Etoposide—testicular cancer	0.000141	0.00237	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000141	0.00236	CcSEcCtD
Abiraterone—Dyspnoea—Ifosfamide—testicular cancer	0.000141	0.00236	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—testicular cancer	0.000141	0.00236	CcSEcCtD
Abiraterone—Discomfort—Cisplatin—testicular cancer	0.00014	0.00235	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—testicular cancer	0.000139	0.00234	CcSEcCtD
Abiraterone—Vomiting—Vinblastine—testicular cancer	0.000139	0.00233	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000136	0.00229	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—testicular cancer	0.000136	0.00228	CcSEcCtD
Abiraterone—Fatigue—Ifosfamide—testicular cancer	0.000136	0.00228	CcSEcCtD
Abiraterone—Oedema—Cisplatin—testicular cancer	0.000136	0.00228	CcSEcCtD
Abiraterone—Infection—Cisplatin—testicular cancer	0.000135	0.00227	CcSEcCtD
Abiraterone—Constipation—Ifosfamide—testicular cancer	0.000135	0.00226	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—testicular cancer	0.000135	0.00226	CcSEcCtD
Abiraterone—Cough—Etoposide—testicular cancer	0.000133	0.00224	CcSEcCtD
Abiraterone—Asthenia—Bleomycin—testicular cancer	0.000133	0.00222	CcSEcCtD
Abiraterone—Skin disorder—Cisplatin—testicular cancer	0.000132	0.00222	CcSEcCtD
Abiraterone—Hypertension—Etoposide—testicular cancer	0.000132	0.00221	CcSEcCtD
Abiraterone—Chest pain—Etoposide—testicular cancer	0.00013	0.00218	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—testicular cancer	0.000129	0.00217	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000129	0.00217	CcSEcCtD
Abiraterone—Discomfort—Etoposide—testicular cancer	0.000129	0.00216	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000128	0.00215	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—testicular cancer	0.000127	0.00213	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000125	0.0021	CcSEcCtD
Abiraterone—Body temperature increased—Ifosfamide—testicular cancer	0.000125	0.00209	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000124	0.00208	CcSEcCtD
Abiraterone—Infection—Etoposide—testicular cancer	0.000124	0.00208	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—testicular cancer	0.000124	0.00207	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000122	0.00205	CcSEcCtD
Abiraterone—Dyspnoea—Cisplatin—testicular cancer	0.000121	0.00204	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—testicular cancer	0.000121	0.00203	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—testicular cancer	0.00012	0.00201	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000118	0.00199	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—testicular cancer	0.000118	0.00198	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—testicular cancer	0.000118	0.00198	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—testicular cancer	0.000118	0.00197	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000118	0.00197	CcSEcCtD
Abiraterone—Vomiting—Bleomycin—testicular cancer	0.000117	0.00197	CcSEcCtD
Abiraterone—Infestation—Methotrexate—testicular cancer	0.000117	0.00196	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—testicular cancer	0.000117	0.00196	CcSEcCtD
Abiraterone—Rash—Bleomycin—testicular cancer	0.000116	0.00195	CcSEcCtD
Abiraterone—Dermatitis—Bleomycin—testicular cancer	0.000116	0.00195	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000116	0.00195	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000114	0.00192	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—testicular cancer	0.000114	0.0019	CcSEcCtD
Abiraterone—Asthenia—Ifosfamide—testicular cancer	0.000113	0.0019	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—testicular cancer	0.000112	0.00187	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—testicular cancer	0.000111	0.00186	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—testicular cancer	0.000111	0.00186	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—testicular cancer	0.00011	0.00185	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—testicular cancer	0.00011	0.00184	CcSEcCtD
Abiraterone—Infestation—Epirubicin—testicular cancer	0.00011	0.00184	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—testicular cancer	0.00011	0.00184	CcSEcCtD
Abiraterone—Rash—Dactinomycin—testicular cancer	0.000109	0.00182	CcSEcCtD
Abiraterone—Diarrhoea—Ifosfamide—testicular cancer	0.000108	0.00181	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000108	0.00181	CcSEcCtD
Abiraterone—Body temperature increased—Cisplatin—testicular cancer	0.000108	0.0018	CcSEcCtD
Abiraterone—Fatigue—Etoposide—testicular cancer	0.000108	0.0018	CcSEcCtD
Abiraterone—Constipation—Etoposide—testicular cancer	0.000107	0.00179	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—testicular cancer	0.000107	0.00179	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000106	0.00177	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—testicular cancer	0.000105	0.00176	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—testicular cancer	0.000104	0.00175	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—testicular cancer	0.000104	0.00174	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—testicular cancer	0.000103	0.00173	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000103	0.00172	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—testicular cancer	0.000102	0.00171	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—testicular cancer	0.000101	0.0017	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—testicular cancer	0.000101	0.0017	CcSEcCtD
Abiraterone—Vomiting—Ifosfamide—testicular cancer	0.0001	0.00168	CcSEcCtD
Abiraterone—Rash—Ifosfamide—testicular cancer	9.95e-05	0.00167	CcSEcCtD
Abiraterone—Dermatitis—Ifosfamide—testicular cancer	9.95e-05	0.00167	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—testicular cancer	9.86e-05	0.00165	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—testicular cancer	9.86e-05	0.00165	CcSEcCtD
Abiraterone—Asthenia—Cisplatin—testicular cancer	9.77e-05	0.00164	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—testicular cancer	9.76e-05	0.00164	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—testicular cancer	9.72e-05	0.00163	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—testicular cancer	9.67e-05	0.00162	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—testicular cancer	9.67e-05	0.00162	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—testicular cancer	9.64e-05	0.00162	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—testicular cancer	9.54e-05	0.0016	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—testicular cancer	9.47e-05	0.00159	CcSEcCtD
Abiraterone—Diarrhoea—Cisplatin—testicular cancer	9.31e-05	0.00156	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—testicular cancer	9.21e-05	0.00154	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—testicular cancer	9.13e-05	0.00153	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—testicular cancer	8.99e-05	0.00151	CcSEcCtD
Abiraterone—Asthenia—Etoposide—testicular cancer	8.95e-05	0.0015	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—testicular cancer	8.95e-05	0.0015	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—testicular cancer	8.93e-05	0.0015	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—testicular cancer	8.92e-05	0.0015	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—testicular cancer	8.87e-05	0.00149	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—testicular cancer	8.79e-05	0.00147	CcSEcCtD
Abiraterone—Vomiting—Cisplatin—testicular cancer	8.65e-05	0.00145	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—testicular cancer	8.62e-05	0.00145	CcSEcCtD
Abiraterone—Rash—Cisplatin—testicular cancer	8.58e-05	0.00144	CcSEcCtD
Abiraterone—Dermatitis—Cisplatin—testicular cancer	8.57e-05	0.00144	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—testicular cancer	8.53e-05	0.00143	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—testicular cancer	8.46e-05	0.00142	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—testicular cancer	8.45e-05	0.00142	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—testicular cancer	8.26e-05	0.00139	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—testicular cancer	8.2e-05	0.00138	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—testicular cancer	8.13e-05	0.00136	CcSEcCtD
Abiraterone—Cough—Methotrexate—testicular cancer	7.99e-05	0.00134	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—testicular cancer	7.98e-05	0.00134	CcSEcCtD
Abiraterone—Vomiting—Etoposide—testicular cancer	7.93e-05	0.00133	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—testicular cancer	7.92e-05	0.00133	CcSEcCtD
Abiraterone—Rash—Etoposide—testicular cancer	7.86e-05	0.00132	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—testicular cancer	7.85e-05	0.00132	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—testicular cancer	7.79e-05	0.00131	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—testicular cancer	7.79e-05	0.00131	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	7.74e-05	0.0013	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—testicular cancer	7.7e-05	0.00129	CcSEcCtD
Abiraterone—Cough—Epirubicin—testicular cancer	7.47e-05	0.00125	CcSEcCtD
Abiraterone—Infection—Methotrexate—testicular cancer	7.42e-05	0.00124	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—testicular cancer	7.39e-05	0.00124	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—testicular cancer	7.32e-05	0.00123	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—testicular cancer	7.29e-05	0.00122	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—testicular cancer	7.29e-05	0.00122	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—testicular cancer	7.25e-05	0.00122	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	7.24e-05	0.00121	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—testicular cancer	7.2e-05	0.00121	CcSEcCtD
Abiraterone—Oedema—Epirubicin—testicular cancer	6.99e-05	0.00117	CcSEcCtD
Abiraterone—Infection—Epirubicin—testicular cancer	6.94e-05	0.00116	CcSEcCtD
Abiraterone—Cough—Doxorubicin—testicular cancer	6.91e-05	0.00116	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—testicular cancer	6.84e-05	0.00115	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.8e-05	0.00114	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—testicular cancer	6.79e-05	0.00114	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—testicular cancer	6.76e-05	0.00113	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—testicular cancer	6.75e-05	0.00113	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—testicular cancer	6.75e-05	0.00113	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	6.7e-05	0.00112	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—testicular cancer	6.67e-05	0.00112	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—testicular cancer	6.66e-05	0.00112	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—testicular cancer	6.57e-05	0.0011	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—testicular cancer	6.47e-05	0.00108	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—testicular cancer	6.45e-05	0.00108	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—testicular cancer	6.44e-05	0.00108	CcSEcCtD
Abiraterone—Infection—Doxorubicin—testicular cancer	6.43e-05	0.00108	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.37e-05	0.00107	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—testicular cancer	6.32e-05	0.00106	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—testicular cancer	6.28e-05	0.00105	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—testicular cancer	6.23e-05	0.00105	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—testicular cancer	6.15e-05	0.00103	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—testicular cancer	6.03e-05	0.00101	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—testicular cancer	6.03e-05	0.00101	CcSEcCtD
Abiraterone—Constipation—Epirubicin—testicular cancer	5.98e-05	0.001	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—testicular cancer	5.9e-05	0.00099	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.89e-05	0.000988	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—testicular cancer	5.85e-05	0.000981	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—testicular cancer	5.77e-05	0.000967	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—testicular cancer	5.69e-05	0.000955	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.58e-05	0.000936	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—testicular cancer	5.58e-05	0.000935	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—testicular cancer	5.53e-05	0.000928	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—testicular cancer	5.53e-05	0.000927	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—testicular cancer	5.36e-05	0.000899	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—testicular cancer	5.11e-05	0.000857	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—testicular cancer	5.11e-05	0.000857	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—testicular cancer	5.01e-05	0.000841	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—testicular cancer	4.78e-05	0.000802	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—testicular cancer	4.75e-05	0.000796	CcSEcCtD
Abiraterone—Rash—Methotrexate—testicular cancer	4.71e-05	0.00079	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—testicular cancer	4.7e-05	0.000789	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—testicular cancer	4.64e-05	0.000778	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—testicular cancer	4.44e-05	0.000745	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—testicular cancer	4.42e-05	0.000742	CcSEcCtD
Abiraterone—Rash—Epirubicin—testicular cancer	4.41e-05	0.000739	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—testicular cancer	4.4e-05	0.000738	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—testicular cancer	4.11e-05	0.00069	CcSEcCtD
Abiraterone—Rash—Doxorubicin—testicular cancer	4.08e-05	0.000684	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—testicular cancer	4.07e-05	0.000683	CcSEcCtD
